In vitro efficacy of imipenem-relebactam and cefepime-AAI101 against a global collection of ESBL-positive and carbapenemase-producing Enterobacteriaceae (2020)
Attributed to:
SAMRC Award - University of Oxford
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.ijantimicag.2020.105925
PubMed Identifier: 32084512
Publication URI: http://europepmc.org/abstract/MED/32084512
Type: Journal Article/Review
Parent Publication: International Journal of Antimicrobial Agents
Issue: 1
ISSN: 0924-8579